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Blood flow in the psoriatic plaque is increased, but 
the underlying mechanisms are not known. The aim 
of the present study was to examine whether neuro-
genic factors are important for blood flow regulation 
in the plaque. Local neurogenic mechanisms were 
inhibited by surface anesthesia and central nervous 
control by conduction anesthesia of nerves to the 
psoriatic plaque. The differences in skin perfusion 
before and after anesthesia were measured with a 
laser Doppler perfusion imager. The skin perfusion in 
psoriatic plaques located in hairy skin was unaffected 
M orphologic and functional changes in the cuta-neous vascular system are prominent in psoria-sis . Venules and capillaries are dilated, and . papillary vessels are elongated and convoluted [1-4]. The abnormalities are located mainly in 
the psoriatic plaque but can be seen to a lesser degree in apparently 
unaffected skin of patients with psoriasis [1]. The mechanisms 
underlying tllese vascular abnormalities are unclear, but possible 
altematives include a passive increase of blood flow in the anatom-
ically large superficial vessel system and/or active vasodilating 
mechanisms induced by local autoregulatory mechanisms, cyto-
kines, hormones, or neural factors. Several fuldings indicate a 
neurogenic abnormality in psoriasis. Remission of plaques has been 
described after lesions of the nerve supply to the area [5-7]. The 
psoriatic plaque has been found to contain an increased number of 
neurofilament-positive nerve fibers and increased concentrations of 
the neuropeptides substance P (SP) [8,9] and vasoactive intestinal 
polypeptide [10,11]. SP-containing sensory skin nerve fibers (un-
myelinated C-fibers) are known to induce cutaneous axon-reflex 
vasodilatation [12]. The postulated physiologic mechanism is me-
chanical activation of cutaneous receptors connected to afferent 
C-fibers, causing release of SP and of calcitonin gene-related 
peptide which, through a still incompletely understood cha.in of 
events, leads to a long-lasting local vasodilatation . The high 
concentration of SP and the increased number of SP-containing 
nerves in the psoriatic plaque raise the possibility that cutaneous 
axon-reflex mechanisms are involved in the development and/or 
maintenance of the psoriatic plaque. 
We conducted the present study to test this hypothesis. Because 
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by conduction anesthesia, but surface anesthesia of 
the plaque evoked a marked blood flow reduction. 
The perfusion in ultraviolet-B-irradiated skin, used 
as a control for nonspecific phenomena, was reduced 
after local application of indomethacin but was un-
affected or increased after surface anesthesia. The 
results are compatible with the idea that a local 
neurogenic mechanism (axon-reflex) contributes to 
the high blood flow in the psoriatic plaque. Key words: 
psoriasislpeifllsioulanestl,esia. ] Invest Dermatol 104:872-
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cutaneous axon-reflex vasodilatation is prevented by surface anes-
thesia of the skin [13], we reasoned that if an ongoing axon reflex 
contributed to the high blood flow in a psoriatic plaque, surface 
anesthesia should reduce blood flow in the plaque. To control for 
nonspecific phenomena, we also studied the effect of surface 
anesthesia on an erythe ma of known origin. We used the inflam-
matory reaction induced by exposure to ultraviolet Blight (UVB), 
which is known to involve stimulation of prostaglandin synthesis 
and which is inhibited by prostaglandin-inhibiting factors [14-16]. 
MATERIALS AND METHODS 
Subjects We studied 12 patients (10 men, two women), aged 47 ::!: 16 
years (mean ::!: SO), who had suffered from psoriasis for 26 ::!: 14.5 yea.rs and 
who had psoriatic plaques covering 5% to 20% of the skin surf.~ce . T he 
control group consisted of nine healthy subjects (six men, three women) 
aged 37 ::!: 5 years. All gave their informed conscnt to the study, which was 
approved by the Ethics Committec of the University of Goteborg. 
Blood Flow Measurements Skin blood How was mapped with a laser 
Doppler perfusion imager [17] . A computer-controllcd optical scanncr 
directs a low-power Hc-Ne laser beam, which is moved step by step in a 
rectangular pattem over the skin surface. Thc scanning takcs abollt 4 min 
for a selected skin area of approximately 10 X 10 cm/5 X 5 cm 
(maximal/minimal step length = approximately 1.5/0.8 mm) at a distance 
of 1 7 cm between the scanner head and the skin area of measurement. At 
each of the 4096 measurement sites, the light penetrates the skin to a median 
sampling depth of about 0.2 mm [17,18]. In the presence of moving blood 
cells, a fraction of the light is Doppler shifted, dctected, and converted into 
an electrical signal for further processing. The output signal (expressed in 
V), which is sampled and stored by a personal computer (Copam 386 SXB), 
is related linearly to tissue perfusion . From the captured perfusion va lucs, a 
color-coded image was generated and presented on a monitor. Further 
image processing and data analyses were made on the displayed image, 
which was then presented on a color plotter (HP Paint Jet; Hewlett 
Packard). 
ExpenrnnentruProcedure 
Psoriatic Patiell/s: The psoriatic patients were instructed to use no active 
treatment and to apply neutral ointment (Essex Cream; Schering-Plough) 
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on the skin during the last wcek before the experiment to prevent extcnsivc 
scaling. Experiments werc performcd under standard indoor conditions 
(22 :!: 1°C. 50% to 60% humidity) after a 20-min acclimatization period. 
Two or three rectangular self-adhesivc framcs (intemal sizc 3 X 4 cm) werc 
cut out of a 2-mm-thick hydrocoloid drcssing (Duoderm; Convatec, Bristol 
Myer Squibb, England) and fastcncd to a skin region containing both 
psoriatic and uninvolvcd skin on the forearm or lower leg. O ne of the 
chambers so created was fillcd with 5 ml lidocainc-prilocaine cream 
(eutectic mixture of local ancsthctics, EMLA; Astra , Sweden) (10 subjects) 
and a sccond chamber with 5 ml EMLA-placcbo cream (containing the 
veh.icle uscd in the EMLA crcam) (cight subjccts) and occluded for 1 h. T hc 
third chamber was cmpty and was occluded in the same way (six subjccts). 
Skin blood flow was mcasured using the maximal step Icngth that allowed 
inclusion of a 10 cm X 10 cm area containing both the psoriatic plaque and 
unaffected skin. Measuremcnts were done immcdiately before application 
and directly aftcr careful rcmoval of the EMLA and EMLA placebo. and 
then sequcntially with a new measurement starting every 5 min fo r 30 min 
after removal. To eliminate interfercncc from ambient light, the electrical 
light was switched off during the scanning procedure. 
In two subjccts with psoriati c plaques on the dorsal surface of the hand, 
regional ancstllesia of thc skin arca was achieved by infiltrating 2 ml 
mepivacaine (Carbocain 20 mg/ml; Astra) around the dorsal cutaneous 
branches of the ulnar and radial nerves at the wrist. The absence of pinprick 
sensation was taken as the criterion for adequa te regional anesthesia. EMLA 
was then appLied in a chamber in the anesthetized region in the same way 
as described above. Blood flow measurements were perfomled before and 
after rcgional anesthesia and after EMLA had been applied fo r 1 h and 
removed. 
CO lltl'O/ S IIbjects: Erythcma was induced in nine healthy subjects by expo-
sure to UVB using a UVB irradiator consisting of 2 Philips TL 20/12W 
fluorescence tubes. T he UVB Ruence rate measured at the skin surface level 
was 0.77 m W Icm 2 (IL 1350; Dexter Industrial Green, Newburyport, MA). 
For each subject, the minimal erythcma dosc (MED) was mcasured 
ventrally on the forearm or upper arm, and the subjects were then exposed 
to 2 MED in the samc region on the other aml. Indomethacin gel (MSD, 
1 %, 0.15 ml) and EMLA (0 .15 ml) wcre applied under occlusion in circular 
hydrocoloid chambcrs 1 cm in diameter in the UVB-treated area either 1 or 
6 h after exposure. EMLA placebo (0.15 ml) was applied for 1 h, and 
occlusion only was applied for 6 h. T he perfusion rates were compared after 
removal of thc creams, i. e., 7 h after thc UVB e""posure. T hese measure-
ments were made in a 5 cm X 5 cm skin area using the minimal step lengtlls . 
Statistics T he average perfusion in each framed area was calculated, but 
if thc framc contained unaffected skin as well as psoriatic lesions, separate 
perfusion values were calculated for each type of skin. T he mean number 
(:!:SD) of measuring points (pixels) in UVB-irradiated sII/ljects was 106 :!: 31 
and in psoriatic patiellts was 154 :!: 61. When the perfusion was measured 
repeatedly, identical image areas were used to calcula te the perfusion 
changes over time (see Fig 2). Values in the text and figures a.re given as 
means :!: SEM in percent of control values (100')10) or in V. T he significance 
of differences was analyzed using an"lysis of variance, followed by Duncan 
multiple range tcst or Student t test. 
RESULTS 
Basal skin perfu sion was 4.5 ::':: 0.7 V in psoriatic plaques and 1.4 ::':: 
0.30 V in unaffected skin 0.5-3 cm away from the plaque (p < 
0.001) (Fig 1). 
Surface Anesthesia Causes Blood Flow Reduction in the 
Psoriatic Plaque After surface anesthesia w ith EM LA cream , 
th e psoriatic plaque was u sually con siderably paler than the sur-
rounding untreated plaque area, and skin perfusion was m arkedly 
reduced (Figs 2, 3) . The maximal reduction of flow (to 59.4 ::':: 
6.1 % of the con trol value, which was set at 100%) always occurred 
in the first measurement after removal of the EMLA cream; there 
was then a su ccessive return toward con trol levels lasting approx-
imately 30 min. Directly after removal of the EMLA placebo cream , 
one subject showed local blanching and reduced perfusion in the 
psoriatic les ion . Compared with the EMLA effect, h owever, the 
flow reduction was brief and in the whole material th ere was no 
significant change of perfusion compared with b asal flow (Fig 3) . 
The differen ce in flow reactions b etween EMLA and EMLA-
placebo was statistically significant for 22 min after removal of the 
creams. Occlusion only of a psoriatic plaque region led to a 10% to 
20% increase of perfusion compared with the con trol level. T h e 
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Figure 1. Higher perfusion in the psoriatic plaque compared with 
unaffected skin. Mean perfusion expressed in V .in psoriatic and wlaffected 
skin of the same subjects (n = 10). ,up < 0.001. Enol' bars, SEM. 
effect was statistically significant directly after removal of the 
occlusion, but not thereafter. 
In unaffected skin of psoriatic patients, surface anesthesia witll 
EMLA did not affect th e perfusion (control perfusion 1.5 ::':: 0.1 V; 
after EMLA treatment 1.6 ::':: 0.3 V). There was also no change of 
perfusion in the psoriatic plaque upon application of conduction 
anesthesia of the nerve to the plaque area (Fig 4). 
IndoUlethacin, but Not Surface Anesthesia, Causes Blood 
Flow Reduction in UVlJ ErytheUla In eXlleriments with UVB 
treatment, th ere was clear eryth ema in the skin of the healthy 
subjects 7 h after irradiation, and perfusion had increased from 
1.6::':: 0.05 V to 4.6 ::':: 0.2 V (p < 0.001). Application ofEMLA and 
EMLA-placebo creams for 1 h (starting 6 h after UVB exposure) 
had n o significant effects on skin perfusion (Fig 5) . In contrast, after 
application of indomethacin, the UVB-treated skin became paler 
and perfusion was reduced to 68 ::':: 4% of the control level (which 
was set at 100%). 
Ifinstead, treatm ents were applied for 6 h (starting 1 h after UVB 
exposure), EMLA cream induced a 26% (to 126 ::':: 10%) increase of 
perfusion compared with the control level, whereas indometllacin 
still cau sed a 34% (to 66 ::':: 6%) decrease in perfusion (Fig 6). 
Occlu sion only had no significant effect. 
DISCUSSION 
T here were two main findings in the present study. First, after 
surf,lce anesth esia, there was a 40% reduction of perfusion in the 
psoriatic plaque (but not in unaffected skin). In contrast, conduction 
anesthesia did not ch ange the perfusion in the psoriatic plaque. 
Second, surface anesthesia of a UVB-induced erythema caused no 
reduction of skin perfusio n , whereas a reduction did occur after 
indomethacin treatment. 
Blood Flow in the Psoriatic Plaque In previous studies using 
percutaneous/intracutaneous xenon clearance methods [19-21], a 
two- to fivefold increase of blood flow in the psoriatic plaque was 
repor ted, which agrees with our figure of a 3.1 - fold increase in 
perfusion. A 12.8-fold increase was found in a study using the 
conventional laser Doppler technique [21], but this value may be 
less reliable because the microvasculature in the skin is not uni-
formly distributed and therefore perfusion values obtained with 
single-point laser Doppler flow m easurements often differ markedly 
between adjacent skin areas [22]. T lus variability is underlined by 
the large differences between individual pixels seen in our original 
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Figure 2. Demonstration of the reduction in perfusion in the pso-
riatic plaque after surface anesthesia but not after placebo. Effects 
of EMLA and EMLA-placebo on forearm skin perfusion are shown in one 
psoriatic patient. a) Control measurement. T he psoriatic area displays high 
perfusion (red-yellow-green), whereas perfusion is much lower (blue) in 
unaffected skin. T he hydrocoloid frames (and the area outs ide the arm) arc 
shown in gray. Note the large variations in perfusion between individual 
pixels . b) Results at 7 min after removal of creams. Note the large reduction of 
perfusion in the EMLA frame (/0IllL1") as compared with the EMLA-placebo 
frame (upp(?l·). c, If) Results 12 and 27 min after removal of creams, respectively. 
Note the successive increase of perfusion in the EMLA frame. T he mc;an 
perfusion is calculated within the rectangular areas outlined in each image. 
records (Fig 2). Another factor that could influence the variability 
is different thicknesses of the plaques. To minimize this effect, we 
used neutral ointment on the plaques for 1 week before the 
experiment. As the standard errors are small (Fig 1), the plaques are 
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Figure 3. Sunlmarized data on skin perfusion in the psoriatic 
plaque after EMLA, EMLA-placebo, and occlusion . Perfusion (in 
percent of control) after 60-min application of surf.1ce anesthesia with 
EMLA (opell circles; n = 10), EMLA-placebo (closed circles; n = 8), and skin 
occlusion (opell triallgles; n = 6). Significant changes from control: " p < 
0.01; ' p < 0.05. Significant differences between EMLA and EMLA-placebo: 
##p < 0.01; #p < 0.05. EI1"Or bars, SEM. 
likely to have been of comparable thickness. A third r eason for the 
variability b etween pixels (but not m ean values) may b e that the 
lase r Doppler imager records perfusion at each measurement site 
for less than 0.1 second. Although a longer m easure m ent time at 
each site would b e preferable, tlus would prolong the total duration 
of the measurements and impair the time resolution. For example, 
if perfusion were recorded for 1 second at each sitc, a pproximate ly 
1 h would b e required to cover the whole area, w lu ch would make 
it impossible to foUow the time co urse of the c hange of flow. 
T h e reason for the high blood flow in the psoriatic plaque is 
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F igure 4. Conduction anesthesia of the psoriatic plaque causes no 
reduction of perfusion. Comparison of the effects of conduction and 
surface anesthesia on skin perfusion in two subjects. Results show contro l 
(opell circles), perfusion 20 min after conduction anesthesia (OpCII sqllarcs), and 
perfusion after surface anesthesia (closed circles). T he first measurement was 
obtained 1 h after application of the EMLA cream (time zero) . 
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Figure 5. Indomethacin but not EMLA reduces perfusion in UVB 
erythema after 1 h of application. Perfusion in UVB crythemas (control 
flow = 100%) after application ofEMLA. EM LA-placebo, and indometha-
cin . T he creams were applied for 1 h. between 6 and 7 h after irradiation, 
and measurements were made 7 h after a UVB dose of 2 MED (n = 
9) . ' p < 0.05; **p < 0.01. E n"Of IJn rs , SEM. 
unlal0wn , but neural m echanisms and facto rs released from inflam-
matory or endothelial ceJl s would be possible alternatives (either 
alone or in combination) . Conduction anesthesia of the n erves 
umervating the psoriatic plaque did not affect blood flow in the 
plaque, and even though only two patients w ere examined in this 
way, the results make it lUllikely that efferent impulses from the 
central nervous system are important. On the other hand, the 
finding that surface anesthesia of the plaque evoked a marked 
reduction in blood flow Ul the plaque is compatible with the idea 
tha t a local ne urogenic m echanism contributes to the high blood 
flow. 
It is w ell known that m echanical or electrical stimulation of the 
skin ~eads to axon-reflex vasodilatation in a local area around the 
stunulus. T he details of the m echanism underlying this reaction are 
not clear, but it has been suggested that action potentials Ul afferent 
C- and A-delta fiber endings release SP/calcitonin gene-related 
peptide, which themselves have dilating effects, and Ul addition may 
illduce mast ceJl degranulation/ histamine release, which causes 
furth er vasodilatation [1 2,23-26]. Because axon-reflex vasodilata-
tion does not occur in skin anesthetized with EMLA cream [13], the 
flow reduction after surface anesthesia o bserved in the present 
experi.ments would be the expected response if the high blood flow 
Ul the psoriatic plaque were due to an ongoing axon refl ex. 
Inflammation leads to sensitization of afferent nociceptive C-fibers 
endings and an increase in their firing [27], which in turn leads to 
ulcreased release of neuropeptides [28]. Activation of thin (A-delta 
or C) nerve fib ers is known to illduce pain at frequencies above 
1 H z [29], whe reas at lower frequencies, the subject often reports 
an itch [30] . T hus, the clinical experience tha t the psoriatic plaque 
is often pruritic durulg exacerbation [31,32] may, in theory, be 
explained by low-frequency activation of afferent C-fibers, which 
indu ces local vasodila tation and thereby constitutes an importa.nt 
pathophysiologic f.'1c tor in the development of the psoriatic plaque . 
In pruritic psoriatic plaques, topical application of capsaicill, which 
is known to deplete nerve endings of neuropeptides (SP, calcitol1.ul 
gene-related peptide) [33 ,34] , improves the pruritus a.nd redu ces 
the psoriasis severity score [35,36]. T he factor ill.itiatin g and 
maintaining the putative axon-reflex activity is unknown . How-
ever, the fmdulg of increases in the number of mast cells [37,38], 
the number of contact points between nerves and mast cells, 
the number of sensory C-fibers, and the concentrations ofSP in the 
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Figure 6. Indomethacin but not EMLA reduces perfusion in UVB 
erythema after 6 h of application. Perfusion in UVB erythemas (control 
flow = 100%) after application of EM LA occlusion and indomethacin. The 
creams were applied for 6 h, starting 1 h after irradiation, and measu.rements 
were made 7 h after a UVB dose of2 MED (n = 9). **p < 0.01. En·or bnrs, 
SEM. 
psoriatic plaque [8,9] is compatible wi th the important role of th e 
C -fibers Ul the development of the psoriatic plaque. 
T he EMLA-induced reduction of blood flow in the plaque may 
not necessarily be m ediated via nerve fibers; direct effects on 
interstitial inflammatory cells or vascular endothelial cells could 
contribu te. Several vasodilating substan ces such as prostagl31ldins, 
nitric oxide, and histamine are known to be released from such 
cells, and it cannot be excluded that this release is blocked or 
reduced by the m embrane-stabilizing effect of the anesthetic agents 
in the EMLA cream. If so, it is unlikely th at prostaglandins are 
illvolved, as the perfusion of the prostagl31ldin-mediated UVB 
erythem a remained unchan ged after EM LA treatment. In agree-
ment with this, topically applied indomethacin recently has been 
found to have no influence on capsaicin-induced neurogenic ill-
f1ammation [3 9] . 
Blood Flow in UVB Erythema Indomethacul is 1a10wn to 
reduce the intensity of UVB-induced erythem a when given topi-
caUy or ill other preparations [14,15]' In the present study, a 33% 
reduction of p erfusion was found regardless of the application time 
of indomethacul. T illS is Ul accordan ce with previous spectropho-
tome tric findulgs [14] , although the tedullques reflect different 
physio logic phenomen a and are not directly comparable. Blanching 
of the skill has been observed after EMLA treatment [40], but was 
not confirmed Ul the present study of unaffected psoriatic Skill. 
Whether the discrepancy reflects the different methodologic ap-
proaches or nonspecific EMLA effects is unknown. 
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